Larry Kudlow: Canada Should Study Our Deal With Mexico
*By Carlo Versano*
One day after President Trump and Mexican President Enrique Peña Nieto announced the framework for a bilateral trade deal, White House economic adviser Larry Kudlow used the latest U.S.-Mexico agreement "as an example" and told Cheddar it's up to Canada to join the negotiations.
"Canada should study how we put this together," Kudlow said Tuesday during an interview on the north lawn of the White House.
The bilateral framework, which Trump has said may replace NAFTA and what he calls its "bad connotations," was constructed mainly around the auto sector. It will be difficult to enforce without Canada's participation in a trilateral agreement, given various supply-chain complications.
The White House is hoping it can use an agreement with Mexico to force the Canadians back to the table, but it's too early to predict whether that will happen, the National Review's Jack Crowe said Tuesday in a separate interview on Cheddar.
"The optics of them coming to the table at this late stage \[will be\] tough," Crowe said. He added that the administration's positioning of Monday's announcement as a big win may be premature.
Nonetheless, Kudlow said the administration is proud of the progress.
"I don't think a lot of people thought we'd get a Mexico deal," he said.
One company shaking up the startup space is Super.com, which aims to help everyday Americans save money and access credit. Hussein Fazal, CEO and co-founder, joins Cheddar News to break down how the product works.
Disgraced Theranos CEO Elizabeth Holmes is in custody at a Texas prison where she could spend the next 11 years for overseeing a blood-testing hoax that became a parable about greed and hubris in Silicon Valley, according to the Federal Bureau of Prisons.
Wall Street is ticking higher Tuesday in its first trading after Washington struck a tentative deal to avoid a potentially disastrous default on its debt.
AstraZeneca said its cancer-treatment drugs when used following chemotherapy treatment showed positive late-stage trial results for endometrial cancer patients.
